{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:10:58Z","timestamp":1792725058964,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ebiom.2021.103614","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T03:14:27Z","timestamp":1633662867000},"page":"103614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-5049","authenticated-orcid":false,"given":"Jie","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8826-4614","authenticated-orcid":false,"given":"Xiao-Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-0209","authenticated-orcid":false,"given":"Jin-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1616","authenticated-orcid":false,"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2021.103614_bib0001","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2021.103614_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de Mel","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-019-0717-6","article-title":"Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)","volume":"12","author":"Somasundaram","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-018-0678-1","article-title":"Advances in multiple omics of natural-killer\/T cell lymphoma","volume":"11","author":"Xiong","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T Cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103614_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.10.011","article-title":"A phase II study of methotrexate, etoposide, dexamethasone and pegaspargase sandwiched with radiotherapy in the treatment of newly diagnosed, Stage IE to IIE extranodal natural-killer\/T-cell lymphoma","volume":"25","author":"Xu","year":"2017","journal-title":"Nasal-Type. EBioMedicine."},{"key":"10.1016\/j.ebiom.2021.103614_bib0007","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","article-title":"Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type","volume":"131","author":"Yamaguchi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2021.103614_bib0008","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.2147\/OTT.S155930","article-title":"Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer\/T-cell lymphoma in vivo and in vitro","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ebiom.2021.103614_bib0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-017-0644-5","article-title":"Liquid biopsy: a step forward towards precision medicine in urologic malignancies","volume":"16","author":"Di Meo","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2021.103614_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/bcj.2015.10","article-title":"Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-\u03b1 and therapeutic targeting","volume":"5","author":"Xiong","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ebiom.2021.103614_bib0011","doi-asserted-by":"crossref","first-page":"e0","DOI":"10.1038\/bcj.2017.61","article-title":"MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma","volume":"7","author":"Xiong","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ebiom.2021.103614_bib0012","first-page":"S397","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2019\/20: transporters","volume":"176","author":"Alexander","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0013","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: New views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ebiom.2021.103614_bib0014","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ccell.2016.09.006","article-title":"Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential","volume":"30","author":"Chen","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103614_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15580","article-title":"SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia","volume":"183","author":"Zhao","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0016","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1038\/leu.2017.160","article-title":"Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy","volume":"31","author":"Grzes","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2021.103614_bib0017","first-page":"2030","article-title":"BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis","volume":"8","author":"Qiu","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ebiom.2021.103614_bib0018","first-page":"915","article-title":"Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling","volume":"20","author":"Fan","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ebiom.2021.103614_bib0019","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2021.103614_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2021.103614_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2021.103614_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ebiom.2021.103614_bib0023","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.ebiom.2021.103614_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","article-title":"MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2021.103614_bib0025","first-page":"1","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Statis Software"},{"key":"10.1016\/j.ebiom.2021.103614_bib0026","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1172\/JCI44474","article-title":"Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria","volume":"121","author":"Bailey","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103614_bib0027","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2021.103614_bib0028","unstructured":"Drexler H., Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma, 6."},{"key":"10.1016\/j.ebiom.2021.103614_bib0029","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/1078-0432.CCR-05-1426","article-title":"Expression of interleukin-9 in nasal natural killer\/T-Cell lymphoma cell lines and patients","volume":"11","author":"Nagato","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2021.103614_bib0030","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2021.103614_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.04.002","article-title":"The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma","volume":"33","author":"Momcilovic","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103614_bib0032","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.ebiom.2021.103614_bib0033","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1541-7786.MCR-19-0517","article-title":"Glutamine deprivation induces PD-L1 expression via activation of EGFR\/ERK\/c-Jun signaling in renal cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ebiom.2021.103614_bib0034","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103614_bib0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0037","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2019.05.002","article-title":"Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis","volume":"35","author":"Li","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103614_bib0038","doi-asserted-by":"crossref","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","article-title":"Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma","volume":"11","author":"Zhang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2021.103614_bib0039","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","article-title":"Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells","volume":"291","author":"Br\u00f6er","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2021.103614_bib0040","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1021\/bi050987n","article-title":"Individual subunits of the glutamate transporter EAAC1 homotrimer function independently of each other","volume":"44","author":"Grewer","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ebiom.2021.103614_bib0041","doi-asserted-by":"crossref","first-page":"20322","DOI":"10.1002\/jcp.28632","article-title":"High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia","volume":"234","author":"Li","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ebiom.2021.103614_bib0042","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2021.103614_bib0043","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2021.103614_bib0044","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103614_bib0045","first-page":"10","article-title":"Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms","author":"Prestipino","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2021.103614_bib0046","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-19-1409","article-title":"Overcoming genetically based resistance mechanisms to PD-1 blockade","volume":"10","author":"Torrejon","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2021.103614_bib0047","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Molecular Cell"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:09:54Z","timestamp":1762456194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421004072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":47,"alternative-id":["S2352396421004072"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103614","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103614"}}